Login to Your Account

Fosun makes play for India firm Gland Pharma

By Pearl Liu and Bonnie Wang
Staff Writers

Tuesday, May 17, 2016

HONG KONG – In a move to improve its drug manufacturing, research and development capacity as well as to strengthen its international presence, Shanghai Fosun Pharmaceutical (Group) Co. Ltd. made an offer to acquire a 96 percent stake in Gland Pharma Ltd.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription